Clinical Trial Update: Phase Three Clinical Trials of Trivalent Rotavirus Genetic Reassortment Vaccine [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for a trivalent rotavirus genetic reassortment vaccine. The status of the trial is currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rotavirus Gastroenteritis

Drugs mentioned

• Trivalent Rotavirus Genetic Reassortment Vaccine

Snippet

Sponsor: Center for Disease Control and Prevention, Henan Province | Conditions: Randomized, Double-blind | Phase 3 | Status: UNKNOWN